Abstract
Seventy five percent of hospitalized patients with Crohn’s disease suffer from malnutrition. One third of Crohn’s disease patients have a body mass index below 20. Sixty percent of Crohn’s disease patients have sarcopenia. However some inflammatory bowel disease (IBD) patients are obese or suffer from sarcopenic-obesity. IBD patients have many vitamin and nutrient deficiencies, which can lead to important consequences such as hyperhomocysteinemia, which is associated with a higher risk of thromboembolic disease. Nutritional deficiencies in IBD patients are the result of insufficient intake, malabsorption and protein-losing enteropathy as well as metabolic disturbances directly induced by the chronic disease and its treatments, in particular corticosteroids. Screening for nutritional deficiencies in chronic disease patients is warranted. Managing the deficiencies involves simple nutritional guidelines, vitamin supplements, and nutritional support in the worst cases.
Keywords: Crohn's disease, enteral nutrition, malnutrition, metabolism, nutrition, obesity, osteopenia, parenteral nutrition, sarcopenia, ulcerative colitis, vitamins.
Current Drug Targets
Title:Nutrition in Adult Patients with Inflammatory Bowel Disease
Volume: 15 Issue: 11
Author(s): Xavier Hebuterne, Jerome Filippi and Stephane M. Schneider
Affiliation:
Keywords: Crohn's disease, enteral nutrition, malnutrition, metabolism, nutrition, obesity, osteopenia, parenteral nutrition, sarcopenia, ulcerative colitis, vitamins.
Abstract: Seventy five percent of hospitalized patients with Crohn’s disease suffer from malnutrition. One third of Crohn’s disease patients have a body mass index below 20. Sixty percent of Crohn’s disease patients have sarcopenia. However some inflammatory bowel disease (IBD) patients are obese or suffer from sarcopenic-obesity. IBD patients have many vitamin and nutrient deficiencies, which can lead to important consequences such as hyperhomocysteinemia, which is associated with a higher risk of thromboembolic disease. Nutritional deficiencies in IBD patients are the result of insufficient intake, malabsorption and protein-losing enteropathy as well as metabolic disturbances directly induced by the chronic disease and its treatments, in particular corticosteroids. Screening for nutritional deficiencies in chronic disease patients is warranted. Managing the deficiencies involves simple nutritional guidelines, vitamin supplements, and nutritional support in the worst cases.
Export Options
About this article
Cite this article as:
Hebuterne Xavier, Filippi Jerome and Schneider M. Stephane, Nutrition in Adult Patients with Inflammatory Bowel Disease, Current Drug Targets 2014; 15 (11) . https://dx.doi.org/10.2174/1389450115666140930150047
DOI https://dx.doi.org/10.2174/1389450115666140930150047 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response, and/or therapy ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Imaging in Drug Side Effects
Current Medical Imaging Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress
Current Topics in Medicinal Chemistry Current Management of Neonatal Liver Tumors
Current Pediatric Reviews How Valid is Placebo in the Indian Setting?
Central Nervous System Agents in Medicinal Chemistry Anti-Diabetic Compounds and their Patent Information: An Update
Recent Patents on Inflammation & Allergy Drug Discovery TRPV1 Function in Health and Disease
Current Pharmaceutical Biotechnology Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Current Neuropharmacology Monoclonal Antibodies and their Target Specificity Against SARS-CoV-2 Infections: Perspectives and Challenges
Recent Patents on Biotechnology Obesity Modulation - The Role in Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry Patent Review
Combinatorial Chemistry & High Throughput Screening Insight of Engineered Nano-based Biologics Approaches used to Combat Autoimmune Disease using TNF-α & IL Inhibitors
Current Topics in Medicinal Chemistry Recombinant Interleukin-12 for Immunotherapy: A Double-Sided Sword
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Clinical Applications and Biosafety of Human Adult Mesenchymal Stem Cells
Current Pharmaceutical Design Multiple Natural Polymers in Drug and Gene Delivery Systems
Current Medicinal Chemistry Quaternary Structure, Substrate Selectivity and Inhibitor Design for SARS 3C-Like Proteinase
Current Pharmaceutical Design Increasing Sensitivity to Radiotherapy and Chemotherapy by Using Novel Biological Agents that Alter the Tumor Microenvironment
Current Molecular Medicine A Three-gene-based Type 1 Diabetes Diagnostic Signature
Current Pharmaceutical Design The Small Bowel: An Imaging Guide
Current Medical Imaging Atherosclerosis: From the Disruption of Mitochondrial Membrane Potential to the Potential Interventional Strategies
Current Medicinal Chemistry